
Cell Biosciences, Inc.
Cell Biosciences, Inc. is a Palo Alto based start-up company aiming at developing series of biotechnology devices that improve the research quality in the cell signaling pathway elucidation through simultaneous and multiple enzyme activity analysis in a cell. The current technologies in the area involve a large variety of artifacts such as neglection of natural co-factors existent in a natural cell, neglection of the effects caused by the cellular repair mechanism, or protein localization effects being altered. Cell Biosciences, Inc. tackles with the existent problems by using natural live cell as the test tube.
| Company | Cell Biosciences, Inc. |
|---|---|
| URL | http://www.cellbiosciences.com/ |
Cell Biosciences Strengthens Management Team
Cell Biosciences, Inc., a provider of ultrasensitive protein detection and characterization systems to life science researchers, today announced three key
management team additions.
Cell Biosciences Announces New Leadership
Cell Biosciences, Inc., a provider of ultrasensitive protein detection and characterization systems to life science researchers, today announced three important additions to its management team.
Stem Cell Signaling Measured for the 1st Time
Firefly 3000 Assay Platform monitored the Phosphorylation Forms of ERK
CELL BIOSCIENCES INTRODUCES A NANO-FLUIDIC IMMUNOASSAY PLATFORM FOR PROTEIN MEASUREMENT AND IDENTIFICATION
Cell Biosciences announces the introduction of the Firefly?3000 automated blotless immunoassay workstation for quantitative measurement of cell signaling and protein expression. The Firefly system is designed to leverage the knowledge and intuition o...
Cell Biosciences Introduces a Nano-fluidic Immunoassay Platform for Protein Measurement and Identification
Cell Biosciences announces the introduction of the Firefly? 3000 automated blotless immunoassay workstation for quantitative measurement of cell signaling and protein expression. The Firefly system i...
Cell BioSciences Inc. today announced that A. Blaine Bowman has joined its Board as Lead Director.
Bowman’s Arrival Marks the start of Product Commercialization
Boehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
【Announcement of the Establishment of Beijing Office】
We are pleased to announce that Mitsui Ventures has opened a new office in Beijing in September2007.
Mitsui Ventures Launching a New Approach to Seed Financing

